Adverse Events Following Transcatheter Edge-to-Edge Repair (TEER) Using MitraClip: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Registry
The MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published studies, there is limited safety data for its use in clinical practice, hence, we designed this study using data obtained from a safety nationwid...
Saved in:
Published in | Cardiovascular revascularization medicine Vol. 39; pp. 101 - 105 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published studies, there is limited safety data for its use in clinical practice, hence, we designed this study using data obtained from a safety nationwide database to demonstrate the safety profile of MitraClip.
The first two of the five authors independently queried all reported adverse events from the United State Food and Drug Administration [FDA] Manufacturer and User Facility Device Experience [MAUDE] registry from January 2014 to December 2020. The primary end point was trend in reported fatal events obtained from this database. The secondary end points included the causes of reported nonfatal reports from the MAUDE registry. The trend of reported fatal events was assessed using the Cochran Armitage trend test over the period of the study.
During the study period, subjects included 3370 patients whose MitraClip-associated adverse events were reported and captured by MAUDE registry. Of these, 211 were fatal and 3159 nonfatal events. Fatal event reports resulted deaths and reported nonfatal events were from injuries and device system malfunction. This study demonstrated an initial upward trend from 2014 to 2015 then a subsequent statistically significant downward trend in reported fatal events from 2015 to 2020 (Cochran-Armitage test P = 0.039). The peak proportion of reported fatal events occurred in 2015, (n = 44; representing 1.25% of reported adverse events) and lowest proportion of reported fatal events took place in 2020 (n = 19; representing 0.56% of reported adverse events). The most reported nonfatal events were from malfunctioning of MitraClip system (n = 1170; representing 37% of reported nonfatal events), new unremarkable repolarization abnormalities on periprocedural EKG (n = 864; representing 27% of reported nonfatal events), leaflet rupture (n = 651; representing 21% of reported nonfatal events), and cardiogenic shock (n = 170; representing 5% of reported nonfatal events).
This analysis of the MAUDE Registry indicated, especially within the confines of this study's limitations and poor data quality of information, an apparent downward trend of reported fatal events over the study period. Even though conclusive attributions cannot be made regarding this important finding, perhaps, this points to early evidence of a potential institutional or operator learning curve with this device. However, in view of the inferior quality of the data accrued from the MAUDE Registry, more high-precision studies are needed to better understand these changes, as the utility of MitraClip, becomes more established in clinical practice. |
---|---|
AbstractList | The MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published studies, there is limited safety data for its use in clinical practice, hence, we designed this study using data obtained from a safety nationwide database to demonstrate the safety profile of MitraClip.
The first two of the five authors independently queried all reported adverse events from the United State Food and Drug Administration [FDA] Manufacturer and User Facility Device Experience [MAUDE] registry from January 2014 to December 2020. The primary end point was trend in reported fatal events obtained from this database. The secondary end points included the causes of reported nonfatal reports from the MAUDE registry. The trend of reported fatal events was assessed using the Cochran Armitage trend test over the period of the study.
During the study period, subjects included 3370 patients whose MitraClip-associated adverse events were reported and captured by MAUDE registry. Of these, 211 were fatal and 3159 nonfatal events. Fatal event reports resulted deaths and reported nonfatal events were from injuries and device system malfunction. This study demonstrated an initial upward trend from 2014 to 2015 then a subsequent statistically significant downward trend in reported fatal events from 2015 to 2020 (Cochran-Armitage test P = 0.039). The peak proportion of reported fatal events occurred in 2015, (n = 44; representing 1.25% of reported adverse events) and lowest proportion of reported fatal events took place in 2020 (n = 19; representing 0.56% of reported adverse events). The most reported nonfatal events were from malfunctioning of MitraClip system (n = 1170; representing 37% of reported nonfatal events), new unremarkable repolarization abnormalities on periprocedural EKG (n = 864; representing 27% of reported nonfatal events), leaflet rupture (n = 651; representing 21% of reported nonfatal events), and cardiogenic shock (n = 170; representing 5% of reported nonfatal events).
This analysis of the MAUDE Registry indicated, especially within the confines of this study's limitations and poor data quality of information, an apparent downward trend of reported fatal events over the study period. Even though conclusive attributions cannot be made regarding this important finding, perhaps, this points to early evidence of a potential institutional or operator learning curve with this device. However, in view of the inferior quality of the data accrued from the MAUDE Registry, more high-precision studies are needed to better understand these changes, as the utility of MitraClip, becomes more established in clinical practice. OBJECTIVEThe MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published studies, there is limited safety data for its use in clinical practice, hence, we designed this study using data obtained from a safety nationwide database to demonstrate the safety profile of MitraClip.METHODSThe first two of the five authors independently queried all reported adverse events from the United State Food and Drug Administration [FDA] Manufacturer and User Facility Device Experience [MAUDE] registry from January 2014 to December 2020. The primary end point was trend in reported fatal events obtained from this database. The secondary end points included the causes of reported nonfatal reports from the MAUDE registry. The trend of reported fatal events was assessed using the Cochran Armitage trend test over the period of the study.RESULTSDuring the study period, subjects included 3370 patients whose MitraClip-associated adverse events were reported and captured by MAUDE registry. Of these, 211 were fatal and 3159 nonfatal events. Fatal event reports resulted deaths and reported nonfatal events were from injuries and device system malfunction. This study demonstrated an initial upward trend from 2014 to 2015 then a subsequent statistically significant downward trend in reported fatal events from 2015 to 2020 (Cochran-Armitage test P = 0.039). The peak proportion of reported fatal events occurred in 2015, (n = 44; representing 1.25% of reported adverse events) and lowest proportion of reported fatal events took place in 2020 (n = 19; representing 0.56% of reported adverse events). The most reported nonfatal events were from malfunctioning of MitraClip system (n = 1170; representing 37% of reported nonfatal events), new unremarkable repolarization abnormalities on periprocedural EKG (n = 864; representing 27% of reported nonfatal events), leaflet rupture (n = 651; representing 21% of reported nonfatal events), and cardiogenic shock (n = 170; representing 5% of reported nonfatal events).CONCLUSIONSThis analysis of the MAUDE Registry indicated, especially within the confines of this study's limitations and poor data quality of information, an apparent downward trend of reported fatal events over the study period. Even though conclusive attributions cannot be made regarding this important finding, perhaps, this points to early evidence of a potential institutional or operator learning curve with this device. However, in view of the inferior quality of the data accrued from the MAUDE Registry, more high-precision studies are needed to better understand these changes, as the utility of MitraClip, becomes more established in clinical practice. |
Author | Dodoo, Sheriff N. Oseni, Abdullahi Okoh, Alexis K. Okafor, Henry E. Odiete, Oghenerukevwe |
AuthorAffiliation | c Division of Cardiology, Department of Medicine, Oklahoma University College of Medicine, United States of America b Division of Cardiology, Department of Medicine, Emory University School of Medicine, United States of America e Division of Cardiology, Department of Medicine, Vanderbilt University School of Medicine, United States of America a Department of Internal Medicine, Piedmont Newnan Hospital, United States of America d Peach-state Advanced Cardiac and Endovascular Center, Newnan, Georgia |
AuthorAffiliation_xml | – name: d Peach-state Advanced Cardiac and Endovascular Center, Newnan, Georgia – name: a Department of Internal Medicine, Piedmont Newnan Hospital, United States of America – name: e Division of Cardiology, Department of Medicine, Vanderbilt University School of Medicine, United States of America – name: b Division of Cardiology, Department of Medicine, Emory University School of Medicine, United States of America – name: c Division of Cardiology, Department of Medicine, Oklahoma University College of Medicine, United States of America |
Author_xml | – sequence: 1 givenname: Sheriff N. surname: Dodoo fullname: Dodoo, Sheriff N. email: sheriff.dodoo@gmail.com organization: Department of Internal Medicine, Piedmont Newnan Hospital, United States of America – sequence: 2 givenname: Alexis K. surname: Okoh fullname: Okoh, Alexis K. organization: Division of Cardiology, Department of Medicine, Emory University School of Medicine, United States of America – sequence: 3 givenname: Abdullahi surname: Oseni fullname: Oseni, Abdullahi organization: Division of Cardiology, Department of Medicine, Oklahoma University College of Medicine, United States of America – sequence: 4 givenname: Oghenerukevwe surname: Odiete fullname: Odiete, Oghenerukevwe organization: Peach-state Advanced Cardiac and Endovascular Center, Newnan, Georgia – sequence: 5 givenname: Henry E. surname: Okafor fullname: Okafor, Henry E. organization: Division of Cardiology, Department of Medicine, Vanderbilt University School of Medicine, United States of America |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34610901$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU2P0zAQjdAi9gP-AUI-dg8ptpPGCQdWVTcFpFZIq_ZsTZxJ11VqF9sN9EfxH3HpsoILp3nSvI_RvOvkwliDSfKW0TGjrHi_HStwDocxp5yNaTWmVLxIrlgpypRWWXkR8WSSpWVWVpfJtfdbSjPBC_EquczygtGKsqvk57Qd0Hkk9YAmeDK3fW-_a7MhKwfGKwiPGNCRut1gGmx6muQB96AdGa3q-uGWrP2JvtTBwazX-w9kgd5b4-MEZ7Alc2d3JPqQJZhDByocXHQE00ZpBHNQutfhSO5x0Cpe8mOPTqOJcLScru_r2xi40T644-vkZQe9xzdP8yZZz-vV7HO6-Prpy2y6SFVe5CFVXKFiZZkr4Ew00DFsoWuarlMNL0XGG5VlmNNWnEiUqwrERFEQ2CmRA8tukruz7_7Q7LBV8TUOerl3egfuKC1o-e_G6Ee5sYNktKwmuSiiw-jJwdlvB_RB7rRX2Pdg0B685BNRFVxUgkdqfqYqZ7132D3nMCpPVcutPFctT1VLWslYdZS9-_vGZ9GfbiPh45mA8VODRie9-v3WVjtUQbZW_z_hF-duwbA |
CitedBy_id | crossref_primary_10_1016_j_case_2022_07_004 crossref_primary_10_1097_PTS_0000000000001220 crossref_primary_10_1016_j_carrev_2023_01_005 |
Cites_doi | 10.1016/j.ihj.2015.08.025 10.1016/j.jacc.2013.02.094 10.1056/NEJMoa1806640 10.1016/j.ahj.2017.10.013 10.1016/0002-9149(81)90142-9 10.1016/S0195-668X(03)00201-X 10.1016/j.jacc.2013.12.062 10.1016/S0140-6736(09)60692-9 10.1016/S0140-6736(06)69208-8 |
ContentType | Journal Article |
Copyright | 2021 Elsevier Inc. Copyright © 2021 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier Inc. – notice: Copyright © 2021 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.carrev.2021.09.007 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-0938 |
EndPage | 105 |
ExternalDocumentID | 10_1016_j_carrev_2021_09_007 34610901 S1553838921006692 |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: T32 HL130025 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5VS 6PF 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAWTL AAXUO ABBQC ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K Z5R ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c464t-c2cec1884ca217baf1edafbbffcb28732bc33e40d7188402c9a75c0a7efc74a13 |
IEDL.DBID | .~1 |
ISSN | 1553-8389 |
IngestDate | Tue Sep 17 21:28:46 EDT 2024 Wed Dec 04 03:01:43 EST 2024 Fri Dec 06 02:42:07 EST 2024 Sat Nov 02 11:57:58 EDT 2024 Fri Feb 23 02:40:29 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | MitraClip Adverse events Fatal events |
Language | English |
License | Copyright © 2021 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c464t-c2cec1884ca217baf1edafbbffcb28732bc33e40d7188402c9a75c0a7efc74a13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895476 |
PMID | 34610901 |
PQID | 2579627972 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10895476 proquest_miscellaneous_2579627972 crossref_primary_10_1016_j_carrev_2021_09_007 pubmed_primary_34610901 elsevier_sciencedirect_doi_10_1016_j_carrev_2021_09_007 |
PublicationCentury | 2000 |
PublicationDate | 2022-06-01 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cardiovascular revascularization medicine |
PublicationTitleAlternate | Cardiovasc Revasc Med |
PublicationYear | 2022 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Stone, Lindenfeld, Abraham, Kar, Lim, Mishell (bb0040) 2018; 379 Nkomo, Gardin, Skelton, Gottdiener, Scott, Enriquez-Sarano (bb0005) 2006; 368 Mahabir, DeFilippis, Aggarwal, Bath, Qamar, Patel (bb0065) 2020; 32 Lung, Baron, Butchart, Delahaye, Gohlke-Bärwolf, Levang (bb0015) 2003; 24 Vahanian, Alfieri, Andreotti, Antunes, Baron-Esquivias, Baumgartner (bb0025) 2013; 14 Benjamin, David, Gregory, Englander (bb0060) 2018; 198 Kelley, Lazkani, Farah, Pershad (bb0055) 2016; 68 MAUDE (bb0050) Maisano, Franzen, Baldus, Schäfer, Hausleiter, Butter (bb0030) 2013; 62 Otto, Nishimura, Bonow, Carabello, Erwin, Gentile (bb0045) 2021; 143 Glower, Kar, Trento, Lim, Bajwa, Quesada (bb0035) 2014; 64 Enriquez-Sarano, Akins, Vahanian (bb0010) 2009; 373 Phillips, Levine, Carter, Boucher, Osbakken, Okada (bb0020) 1981; 48 Glower (10.1016/j.carrev.2021.09.007_bb0035) 2014; 64 Enriquez-Sarano (10.1016/j.carrev.2021.09.007_bb0010) 2009; 373 Lung (10.1016/j.carrev.2021.09.007_bb0015) 2003; 24 Nkomo (10.1016/j.carrev.2021.09.007_bb0005) 2006; 368 Mahabir (10.1016/j.carrev.2021.09.007_bb0065) 2020; 32 Stone (10.1016/j.carrev.2021.09.007_bb0040) 2018; 379 Otto (10.1016/j.carrev.2021.09.007_bb0045) 2021; 143 MAUDE (10.1016/j.carrev.2021.09.007_bb0050) Kelley (10.1016/j.carrev.2021.09.007_bb0055) 2016; 68 Benjamin (10.1016/j.carrev.2021.09.007_bb0060) 2018; 198 Maisano (10.1016/j.carrev.2021.09.007_bb0030) 2013; 62 Phillips (10.1016/j.carrev.2021.09.007_bb0020) 1981; 48 Vahanian (10.1016/j.carrev.2021.09.007_bb0025) 2013; 14 |
References_xml | – volume: 62 start-page: 1052 year: 2013 end-page: 1061 ident: bb0030 article-title: Percutaneous mitral valve interventions in the real world: early and 1- year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip therapy in Europe publication-title: J Am Coll Cardiol contributor: fullname: Butter – volume: 373 start-page: 1382 year: 2009 end-page: 1394 ident: bb0010 article-title: Mitral regurgitation publication-title: Lancet contributor: fullname: Vahanian – ident: bb0050 article-title: Manufacturer and user facility device experience contributor: fullname: MAUDE – volume: 24 start-page: 1231 year: 2003 end-page: 1243 ident: bb0015 article-title: A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease publication-title: Eur Heart J contributor: fullname: Levang – volume: 368 start-page: 1005 year: 2006 end-page: 1011 ident: bb0005 article-title: Burden of valvular heart diseases: a population-based study publication-title: Lancet. contributor: fullname: Enriquez-Sarano – volume: 14 start-page: 167 year: 2013 end-page: 214 ident: bb0025 article-title: Joint task force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) publication-title: G Ital Cardiol (Rome) contributor: fullname: Baumgartner – volume: 68 start-page: 399 year: 2016 end-page: 404 ident: bb0055 article-title: Percutaneous mitral valve repair: a new treatment for mitral regurgitation publication-title: Indian Heart J contributor: fullname: Pershad – volume: 379 start-page: 2307 year: 2018 end-page: 2318 ident: bb0040 article-title: Transcatheter mitral-valve repair in patients with heart failure publication-title: N Engl J Med contributor: fullname: Mishell – volume: 48 start-page: 647 year: 1981 end-page: 654 ident: bb0020 article-title: Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction publication-title: Am J Cardiol contributor: fullname: Okada – volume: 64 start-page: 172 year: 2014 end-page: 181 ident: bb0035 article-title: Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study publication-title: J Am Coll Cardiol contributor: fullname: Quesada – volume: 198 start-page: 64 year: 2018 end-page: 74 ident: bb0060 article-title: Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and MitraClip procedures as reported by the transcatheter valve therapy registry and the Food and Drug Administration postmarket surveillance data publication-title: Am Heart J contributor: fullname: Englander – volume: 32 start-page: E130 year: 2020 end-page: E132 ident: bb0065 article-title: The first 4 years of postmarketing safety surveillance related to the MitraClip device: a United States Food and Drug Administration MAUDE experience publication-title: J Invasive Cardiol contributor: fullname: Patel – volume: 143 start-page: e72 year: 2021 end-page: e227 ident: bb0045 article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines publication-title: Circulation contributor: fullname: Gentile – volume: 68 start-page: 399 year: 2016 ident: 10.1016/j.carrev.2021.09.007_bb0055 article-title: Percutaneous mitral valve repair: a new treatment for mitral regurgitation publication-title: Indian Heart J doi: 10.1016/j.ihj.2015.08.025 contributor: fullname: Kelley – ident: 10.1016/j.carrev.2021.09.007_bb0050 contributor: fullname: MAUDE – volume: 62 start-page: 1052 year: 2013 ident: 10.1016/j.carrev.2021.09.007_bb0030 article-title: Percutaneous mitral valve interventions in the real world: early and 1- year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip therapy in Europe publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.02.094 contributor: fullname: Maisano – volume: 379 start-page: 2307 year: 2018 ident: 10.1016/j.carrev.2021.09.007_bb0040 article-title: Transcatheter mitral-valve repair in patients with heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa1806640 contributor: fullname: Stone – volume: 14 start-page: 167 year: 2013 ident: 10.1016/j.carrev.2021.09.007_bb0025 article-title: Joint task force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) publication-title: G Ital Cardiol (Rome) contributor: fullname: Vahanian – volume: 198 start-page: 64 year: 2018 ident: 10.1016/j.carrev.2021.09.007_bb0060 article-title: Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and MitraClip procedures as reported by the transcatheter valve therapy registry and the Food and Drug Administration postmarket surveillance data publication-title: Am Heart J doi: 10.1016/j.ahj.2017.10.013 contributor: fullname: Benjamin – volume: 32 start-page: E130 year: 2020 ident: 10.1016/j.carrev.2021.09.007_bb0065 article-title: The first 4 years of postmarketing safety surveillance related to the MitraClip device: a United States Food and Drug Administration MAUDE experience publication-title: J Invasive Cardiol contributor: fullname: Mahabir – volume: 48 start-page: 647 year: 1981 ident: 10.1016/j.carrev.2021.09.007_bb0020 article-title: Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction publication-title: Am J Cardiol doi: 10.1016/0002-9149(81)90142-9 contributor: fullname: Phillips – volume: 24 start-page: 1231 year: 2003 ident: 10.1016/j.carrev.2021.09.007_bb0015 article-title: A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease publication-title: Eur Heart J doi: 10.1016/S0195-668X(03)00201-X contributor: fullname: Lung – volume: 64 start-page: 172 year: 2014 ident: 10.1016/j.carrev.2021.09.007_bb0035 article-title: Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.12.062 contributor: fullname: Glower – volume: 373 start-page: 1382 year: 2009 ident: 10.1016/j.carrev.2021.09.007_bb0010 article-title: Mitral regurgitation publication-title: Lancet doi: 10.1016/S0140-6736(09)60692-9 contributor: fullname: Enriquez-Sarano – volume: 143 start-page: e72 year: 2021 ident: 10.1016/j.carrev.2021.09.007_bb0045 article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines publication-title: Circulation contributor: fullname: Otto – volume: 368 start-page: 1005 year: 2006 ident: 10.1016/j.carrev.2021.09.007_bb0005 article-title: Burden of valvular heart diseases: a population-based study publication-title: Lancet. doi: 10.1016/S0140-6736(06)69208-8 contributor: fullname: Nkomo |
SSID | ssj0037267 |
Score | 2.3174078 |
Snippet | The MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published... OBJECTIVEThe MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 101 |
SubjectTerms | Adverse events Databases, Factual Fatal events Humans MitraClip Registries United States United States Food and Drug Administration |
Title | Adverse Events Following Transcatheter Edge-to-Edge Repair (TEER) Using MitraClip: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Registry |
URI | https://dx.doi.org/10.1016/j.carrev.2021.09.007 https://www.ncbi.nlm.nih.gov/pubmed/34610901 https://search.proquest.com/docview/2579627972 https://pubmed.ncbi.nlm.nih.gov/PMC10895476 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi4S4IN6Ux8pIHHYPoYnjxAm3qpuoPLIH2Ep7s2zH3g2CtOoDxIV_xH9kxkkKBSQkTqlSJ7Hy2TOe-JtvCHke56ZOE8thijsWcKfTQLkshyilzjLcp0u94k11ls7m_PVFcnFApkMuDNIqe9vf2XRvrfsz4_5tjpdNM36PFW8y8LcQtIDfzNEO8yTEKgYvvu1oHrFgvoosNg6w9ZA-5zleBumwnyFKZJFXO8Wisn93T38uP39nUf7ilspb5Ga_nqSTrsu3yYFt75DrVb9jfpd89xWX15YWSGxc0xJwX3wBf0W9l_KqrfBqaVFf2mCzCPBIYVWumhU9Pi-KdyfUswpo1cDjpx-b5Uv6FqwjDFbqtVltTcvV4hOF-9BKtVvMlNiu4I6qreFS-FEqgwTcr_TUolmiP9WV6XE1mZ8WJ_DAS1917h6Zl8X5dBb0JRoCw1O-CQwz1kSAqlEQ22jlIlsrp7VzRkMsFjNt4tjysBbYKGQmVyIxoRLWGcFVFN8nh-2itQ8JjeNUKBtFaapz8KxM19wIx7TDsWNzMSLBgIxcdkoccqCofZAdkhKRlGEuAckREQN8cm9ESXAW_7jy2YC2hMmGOyiqtYvtWjLM3GUiF2xEHnTo7_oSe-X6MBqRbG9c7BqgkPf-P21z5QW9ozDLEy7SR__d5cfkBsO8DP956Ak53Ky29imsljb6yE-HI3Jt8urN7OwHPu8Xdg |
link.rule.ids | 230,314,780,784,885,4502,24116,27924,27925,45585,45679 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWiwRcEO8tTyNx2D2EJrYTJ9xW3UQFmj1AK-3Nsh17CYKk6gPEhX_Ef2TsJIUCEhKnVKmTWJnxPOJvvkHoOc10lcSGwRK3JGBWJYG0aQZZSpWmbp8u8Yw35XkyXbDXF_HFAZoMtTAOVtnb_s6me2vdnxn3b3O8rOvxO9fxJgV_C0kL-M0M7PAVFkP0C0r94tsO50E58W1k3ejADR_q5zzISzs87GdIE0nk6U5dV9m_-6c_48_fYZS_-KXiJrrRB5T4tJvzLXRgmtvoatlvmd9B333L5bXBuUM2rnEBgm-_gMPC3k152lZ4tzivLk2waQN3xBCWy3qFj-d5_vYEe1gBLmt4_ORjvXyJZ2AeQVuxJ2c1FS5W7ScM98GlbLauVGK7gjvKpoJL4UchtUPgfsVnxtkl_JNeGR-Xp4uz_AQeeOnbzt1FiyKfT6ZB36Mh0Cxhm0ATbXQEYtUSkhslbWQqaZWyVitIxihRmlLDwoq7QSHRmeSxDiU3VnMmI3oPHTZtY44QpjTh0kRRkqgMXCtRFdPcEmWd8piMj1AwSEYsOyoOMWDUPohOksJJUoSZAEmOEB_EJ_ZUSoC3-MeVzwZpC1htbgtFNqbdrgVxpbuEZ5yM0P1O-ru5UE9dH0YjlO7pxW6AY_Le_6ep33tG7yhMs5jx5MF_T_kpujadlzMxe3X-5iG6TlyRhv9W9AgdblZb8xhCp4164pfGD6GNGRM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adverse+Events+Following+Transcatheter+Edge-to-Edge+Repair+%28TEER%29+Using+MitraClip%3A+Lessons+Learned+From+the+Manufacturer+and+User+Facility+Device+Experience+%28MAUDE%29+Registry&rft.jtitle=Cardiovascular+revascularization+medicine&rft.au=Dodoo%2C+Sheriff+N.&rft.au=Okoh%2C+Alexis+K.&rft.au=Oseni%2C+Abdullahi&rft.au=Odiete%2C+Oghenerukevwe&rft.date=2022-06-01&rft.issn=1553-8389&rft.eissn=1878-0938&rft.volume=39&rft.spage=101&rft.epage=105&rft_id=info:doi/10.1016%2Fj.carrev.2021.09.007&rft_id=info%3Apmid%2F34610901&rft.externalDBID=PMC10895476 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-8389&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-8389&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-8389&client=summon |